NQ [NQ Mobile] SC 13G/A: (Original Filing)

[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 5,882,315 Item 6: 0 Item 7: 6,569,315 Item 8: 0 Item 9: 6,569,315 Item 11: 14.104% Item 12: HC Cusip #64118U926 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 6,569,315 Item 8: 0 Item 9: 6,569,315 Item 11: 14.104%]

By | 2016-03-11T09:48:57+00:00 October 3rd, 2012|Categories: Chinese Stocks, NQ, SEC Original|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] 6-K: (Original Filing)

[EXECUTION VERSION CHINARD BLOODRPORATION 7% SENIORNVERTIBLE NOTE Original Principal Amount: US$50,000,000mpany Holder Principal and Issuancete and Note Notes Other Notes Registration Rightsreement FOR VALUE RECEIVED, Chinard Bloodrporation, an exemptedmpany with limited liabilityorporated in theyman Islands (the 1. Rank pari passu] [EXECUTION VERSION REGISTRATION RIGHTSREEMENT between CHINARD BLOODRPORATION and GOLDEN MEDITECHS LIMITEDted October 3, 2012 TABLE OFNTENTS Page Section 1 DEFINITIONS 1 Section 2 GENERAL; SECURITIES SUBJECT TO THISREEMENT 5 Section 3 MANDATORY REGISTRATION 5 Section 4 DEMAND REGISTRATION RIGHTS 8 Section 5IDENTAL OR PIGGY-BACK REGISTRATION] [Chinard Bloodrporation Announcesmpletion of $50 Millionnvertible Note Financing with Golden Meditech HONG KONG, China, October 3, 2012 Chinard Bloodrporation (NYSE:) (CCBC or thempany), the first and largestrd blood banking operator in China, announced that it has successfullympleted the previously announced The board of directors of CCBC has appointed Mr. Yuen Kam, currently the Chairman and]

By | 2016-02-04T16:37:09+00:00 October 3rd, 2012|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[TPI Reports Fiscal Year 2012 Financial Results CHENGDU, China, September 28, 2012 Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the fiscal year 2012. Fiscal Year 2012 Ended June 30, 2012 Financial Highlights: ● FY2012 revenue delivered] [Tianyin Pharmaceutical Co., Inc. Fiscal 2012 Earnings Call September 28, 2012 Operator: I would now like to turn the conference over to our host, Dr. James Tong, Chief Financial Officer. Please go ahead, sir. Dr. James Tong: Fiscal year 2012 financial highlights. Revenue delivered $69.6 million, compared with $95.2 million in fiscal year 2011. Operating income delivered $8.5 million, compared] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT September 28, 2012 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By | 2016-03-27T19:12:44+00:00 October 3rd, 2012|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

AMCF [Andatee China Marine Fuel Services] 8-K: (Original Filing)

[FORM 8-K CURRENT REPORT Date of Report (Date of earliest event reported): September 5, 2012 Andatee China Marine Fuel Services Corporation Delaware 001-34608 80-0445030 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) 290 Kangji East Building 22nd Floor, Tianmu West Road, Zhabei District, Shanghai City, People’s Republic of China 011 (8621) 50152581 N/A (Former name or former]

XIN [Xinyuan Real Estate] 6-K: (Original Filing)

[Xinyuan Real Estate Co., Ltd. ACQUIRES PARCEL OF LAND IN Beijing BEIJING, China, October 1, 2012 Xinyuan paid a total of RMB1,030 million (US$162.4 million) for the unencumbered land use rights for the parcel, which offers a total site area of 57,862 square meters. Based on pre-planning of the proposed development, the estimated gross floor area is approximately 130,000 square] []

JKS [JinkoSolar] 6-K: (Original Filing)

[JinkoSolar Schedules 2012 Annual General Meeting to be Held on October 22, 2012 SHANGHAI, September 29, 2012 - JinkoSolar Holding Co., Ltd. (“JinkoSolar” or the ”Company”) (NYSE: JKS), a leading global solar power product manufacturer, today announced that it will hold its 2012 annual general meeting on Monday, October 22, 2012 at 10:00 a.m.(Beijing time) at Lilac 1, 3/F Parkview] [JINKOSOLAR HOLDING CO., LTD. (incorporated in the Cayman Islands with limited liability) NOTICE OF ANNUAL GENERAL MEETING TO BE HELD ON OCTOBER 22, 2012 NOTICE IS HEREBY GIVEN · To consider and, if thought fit, pass the following resolutions: As ordinary resolutions: 1. 2. 3. That Ernst & Young Hua Ming be re-appointed as auditors of the Company for the] [JINKOSOLAR HOLDING CO., LTD. (incorporated in the Cayman Islands with limited liability) FORM OF PROXY FOR THE ANNUAL GENERAL MEETING (OR ANY ADJOURNMENT THEREOF) TO BE HELD ON OCTOBER 22, 2012 We,_____________________________________of___________________________________________________, being the registered holder of ______________ordinary shares, par value US$0.00002 per share of JINKOSOLAR HOLDING CO., LTD. (the “Company”) hereby appoint ________________________, or failing him/her, the chairman of]

By | 2016-02-29T09:43:41+00:00 October 1st, 2012|Categories: Chinese Stocks, JKS, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar